Prospective Observational Pilot Study of Myo-inositol and D-chiro-inositol (Femsol) in Women with Polycystic Ovary Syndrome in Tobruk, Libya
Libyan Journal of Medical Research · 18.05.2026 · 20 (2) · 271-275
DOI: 10.54361/ljmr.20.2.44 ↗Kurz gefasst
Fachartikel in der Zeitschrift Libyan Journal of Medical Research, online erschienen am 18.05.2026. Verfasst von Inas Yhea und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by reproductive, hormonal, and metabolic dysfunction. Current treatments often show limited efficacy and may be associated with adverse effects Objective To evaluate the efficacy of Femsol in improving clinical symptoms, hormonal profiles, and metabolic parameters in women with PCOS Methods: “A prospective observational pilot study was conducted on 100 women diagnosed with PCOS. Pre- and post-treatment parameters were compared using paired statistical analyses, Pre- and post-treatment parameters were compared using paired statistical tests. Due to partial reliance on simulated data and absence of a control group, findings are considered exploratory.
Result
Femsol demonstrated consistent improvements across clinical and biochemical domains. Symptom reduction ranged from 67.6% to 70.0%. Significant reductions were observed in AMH (−39.7%), LH/FSH ratio (−36.5%), testosterone (−31.0%), and HOMA-IR (−30.0%). Approximately 70% of participants met treatment response criteria.
Conclusion
Femsol appears to be a promising “Femsol showed promising preliminary effects on clinical, hormonal, and metabolic parameters in women with PCOS. Further randomised controlled studies are required to confirm these findings as a therapeutic option for PCOS. However, randomised controlled trials are required to confirm these findings.
Zitieren
APA
Yhea, I., naji, W., abduljawad, S., almutkhatri, R., Mohammed, F., makhzoum, S., Ashour, B., & amtoubil, M. (2026). Prospective Observational Pilot Study of Myo-inositol and D-chiro-inositol (Femsol) in Women with Polycystic Ovary Syndrome in Tobruk, Libya. Libyan Journal of Medical Research, 20(2), 271-275. https://doi.org/10.54361/ljmr.20.2.44
Vancouver
Yhea I, naji W, abduljawad S, almutkhatri R, Mohammed F, makhzoum S, et al. Prospective Observational Pilot Study of Myo-inositol and D-chiro-inositol (Femsol) in Women with Polycystic Ovary Syndrome in Tobruk, Libya. Libyan Journal of Medical Research. 2026;20(2):271-275. doi:10.54361/ljmr.20.2.44
BibTeX
@article{Yhea2026,
author = {Yhea, Inas and naji, Wardah and abduljawad, Sameerah and almutkhatri, Radia and Mohammed, Fayazah and makhzoum, Sarah and Ashour, Bilqyas and amtoubil, Maqboulah},
title = {Prospective Observational Pilot Study of Myo-inositol and D-chiro-inositol (Femsol) in Women with Polycystic Ovary Syndrome in Tobruk, Libya},
journal = {Libyan Journal of Medical Research},
year = {2026},
volume = {20},
number = {2},
pages = {271--275},
doi = {10.54361/ljmr.20.2.44}
}
EUVIMED